Cargando…

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer’s disease

Mostrar otras versiones (1)

BACKGROUND: Age is the strongest risk factor for the development of Alzheimer’s disease (AD). Besides the pathological hallmarks of β-amyloid (Aβ) plaques and neurofibrillary tangles, emerging evidence demonstrates a critical role of microglia and neuroinflammation in AD pathogenesis. Oleoylethanola...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comerota, Michele M., Gedam, Manasee, Xiong, Wen, Jin, Feng, Deng, Lisheng, Wang, Meng C., Wang, Jin, Zheng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426131/ https://www.ncbi.nlm.nih.gov/pubmed/37580742 http://dx.doi.org/10.1186/s13024-023-00648-x

Ejemplares similares

Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer’s disease
por: Comerota, Michele, et al.
Publicado: (2023)

Complement C3aR depletion reverses HIF-1α–induced metabolic impairment and enhances microglial response to Aβ pathology
por: Gedam, Manasee, et al.
Publicado: (2023)

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells
por: Chen, Ling, et al.
Publicado: (2015)

Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization
por: Li, Ying, et al.
Publicado: (2023)

Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats
por: Decara, Juan Manuel, et al.
Publicado: (2012)

Identification of oleoylethanolamide as an endogenous ligand for HIF-3α
por: Diao, Xiaotong, et al.
Publicado: (2022)

FoxO3 deficiency in cortical astrocytes leads to impaired lipid metabolism and aggravated amyloid pathology
por: Du, Shuqi, et al.
Publicado: (2021)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
por: Orio, Laura, et al.
Publicado: (2019)

Oleoylethanolamide attenuates cocaine-primed reinstatement and alters dopaminergic gene expression in the striatum
por: González-Portilla, Macarena, et al.
Publicado: (2023)

mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy
por: Cheng, Lizhen, et al.
Publicado: (2023)

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL
por: Fan, Angran, et al.
Publicado: (2014)

Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
por: Joshi, Utsav, et al.
Publicado: (2018)

Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models
por: Iyaswamy, Ashok, et al.
Publicado: (2022)

Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease
por: Wang, Xueting, et al.
Publicado: (2023)

Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
por: De Filippo, Carlotta, et al.
Publicado: (2023)

Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways
por: Yang, Lichao, et al.
Publicado: (2016)

NHR-49/PPAR-α and HLH-30/TFEB cooperate for C. elegans host defense via a flavin-containing monooxygenase
por: Wani, Khursheed A, et al.
Publicado: (2021)

Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
por: Koethe, Dagmar, et al.
Publicado: (2009)

Oleoylethanolamide‐induced anorexia in rats is associated with locomotor impairment
por: Fedele, Shahana, et al.
Publicado: (2018)

Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
por: Kwon, Eun-Kyung, et al.
Publicado: (2021)

Author Correction: Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
por: Joshi, Utsav, et al.
Publicado: (2019)

Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity
por: Qin, Yeyu, et al.
Publicado: (2022)

Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia
por: Portavella, Manuel, et al.
Publicado: (2018)

Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats
por: Otagiri, Shinsuke, et al.
Publicado: (2020)

Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota
por: Rodríguez-González, Alicia, et al.
Publicado: (2021)

Chronic Oleoylethanolamide Treatment Decreases Hepatic Triacylglycerol Level in Rat Liver by a PPARγ/SREBP-Mediated Suppression of Fatty Acid and Triacylglycerol Synthesis
por: Romano, Adele, et al.
Publicado: (2021)

Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy
por: Yang, Chuanbin, et al.
Publicado: (2022)

TFEB-Mediated Lysosomal Restoration Alleviates High Glucose-Induced Cataracts Via Attenuating Oxidative Stress
por: Sun, Yan, et al.
Publicado: (2022)

The 16α-hydroxylated Bile Acid, Pythocholic Acid Decreases Food Intake and Increases Oleoylethanolamide in Male Mice
por: Higuchi, Sei, et al.
Publicado: (2023)

A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway
por: Park, Jee-Yun, et al.
Publicado: (2021)

Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR-181a2
por: Cheng, Yanjie, et al.
Publicado: (2017)

Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α
por: Zhou, Yufei, et al.
Publicado: (2021)

Oleoylethanolamide Alleviates Hepatic Ischemia-Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress-Associated Apoptosis
por: Qi, Shunli, et al.
Publicado: (2022)

Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023)

Administration of URB597, Oleoylethanolamide or Palmitoylethanolamide Increases Waking and Dopamine in Rats
por: Murillo-Rodríguez, Eric, et al.
Publicado: (2011)

TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer’s disease–relevant phenotypes in mice
por: Li, Tianyou, et al.
Publicado: (2022)

Oleoylethanolamide inhibits α-melanocyte stimulating hormone-stimulated melanogenesis via ERK, Akt and CREB signaling pathways in B16 melanoma cells
por: Zhou, Juan, et al.
Publicado: (2017)

Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways
por: Ma, Zhen-Guo, et al.
Publicado: (2017)

Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein
por: Kilpatrick, Kiri, et al.
Publicado: (2015)

Melatonin Restores Autophagic Flux by Activating the Sirt3/TFEB Signaling Pathway to Attenuate Doxorubicin-Induced Cardiomyopathy
por: Ma, Yanyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_67rc0405cn0m410jfl8i5jkk4o